We create the first closed-loop AI generative biology company to create the new standard of biology intelligence
Funding
Growth Stage
Current Stage
$33M
Recent Funding
$337.1M
Total Funding
Recent News
AstraZeneca, Daiichi Sankyo’s Datroway receives FDA approval for TNBC
Pharmaceutical Technology
Daiichi Sankyo and Waiv partner for ADC biomarkers
Pharmaceutical Technology
OWKIN · 5d ago
Senior Software Engineer (Platform)
Greater London, EnglandHybridSenior Level
OWKIN · 6d ago
Team Lead, Platform Services
United KingdomRemoteLead/Staff
OWKIN · 6d ago
Senior Software Engineer (Platform)
United KingdomRemoteSenior Level
OWKIN · 6d ago
Team Lead, Platform Services
United KingdomRemoteLead/Staff
OWKIN · 1w ago
Director, Biopharma Data Science
United KingdomRemoteDirector/Executive
OWKIN · 4m ago
Senior Software Engineer
United KingdomRemoteSenior Level